Dong S, Fu C, Shu C, Xie M, Li Y, Zou J
JCI Insight. 2024; 9(20).
PMID: 39435662
PMC: 11529984.
DOI: 10.1172/jci.insight.176527.
Patel A, Trageser K, Kim H, Lim W, Adler C, Porter B
Blood Adv. 2024; 8(23):5975-5987.
PMID: 39348688
PMC: 11629214.
DOI: 10.1182/bloodadvances.2023011754.
Han R, Su L, Cheng L
Vaccines (Basel). 2024; 12(9).
PMID: 39340042
PMC: 11436046.
DOI: 10.3390/vaccines12091012.
Saris J, Bootsma S, Verhoeff J, Tuynman J, Wildenberg M, Rijnstra E
Front Immunol. 2024; 15:1415457.
PMID: 39044825
PMC: 11263213.
DOI: 10.3389/fimmu.2024.1415457.
Zhang T, Liu W, Yang Y
Sci China Life Sci. 2024; 67(4):645-652.
PMID: 38270770
DOI: 10.1007/s11427-023-2462-8.
Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis.
Gammelgaard O, Terp M, Kirkin A, Johansen S, Traynor S, Vever H
Mol Cancer. 2024; 23(1):6.
PMID: 38184565
PMC: 10770996.
DOI: 10.1186/s12943-023-01914-8.
Current Advances in Humanized Mouse Models for Studying NK Cells and HIV Infection.
Kim J, Bresson-Tan G, Zack J
Microorganisms. 2023; 11(8).
PMID: 37630544
PMC: 10458594.
DOI: 10.3390/microorganisms11081984.
Humanized MISTRG as a preclinical model to study human neutrophil-mediated immune processes.
Martinez-Sanz P, Laurent A, Slot E, Hoogenboezem M, Babala N, van Bruggen R
Front Immunol. 2023; 14:1105103.
PMID: 36969261
PMC: 10032520.
DOI: 10.3389/fimmu.2023.1105103.
Human Tumor Targeted Cytotoxic Mast Cells for Cancer Immunotherapy.
Fereydouni M, Ahani E, Desai P, Motaghed M, Dellinger A, Metcalfe D
Front Oncol. 2022; 12:871390.
PMID: 35574362
PMC: 9097604.
DOI: 10.3389/fonc.2022.871390.
The establishment and application of CD3E humanized mice in immunotherapy.
Zhang R, Zhang J, Zhou X, Zhao A, Yu C
Exp Anim. 2022; 71(4):442-450.
PMID: 35570001
PMC: 9671771.
DOI: 10.1538/expanim.22-0012.
Current Status, Barriers, and Future Directions for Humanized Mouse Models to Evaluate Stem Cell-Based Islet Cell Transplant.
Verhoeff K, Marfil-Garza B, Cuesta-Gomez N, Jasra I, Dadheech N, Shapiro A
Adv Exp Med Biol. 2022; 1387:89-106.
PMID: 35362861
DOI: 10.1007/5584_2022_711.
Emerging insights in sarcoidosis: moving forward through reverse translational research.
Liu A, Sharma L, Yan X, Dela Cruz C, Herzog E, Ryu C
Am J Physiol Lung Cell Mol Physiol. 2022; 322(4):L518-L525.
PMID: 35196896
PMC: 8957321.
DOI: 10.1152/ajplung.00266.2021.
Preclinical Models for the Study of Lung Cancer Pathogenesis and Therapy Development.
Arnal-Estape A, Foggetti G, Starrett J, Nguyen D, Politi K
Cold Spring Harb Perspect Med. 2021; 11(12).
PMID: 34518338
PMC: 8634791.
DOI: 10.1101/cshperspect.a037820.
Human delta like 1-expressing human mesenchymal stromal cells promote human T cell development and antigen-specific response in humanized NOD/SCID/IL-2R[Formula: see text] (NSG) mice.
Kwon D, Park J, Lee J, Kim S, Choi B, Lee K
Sci Rep. 2021; 11(1):10603.
PMID: 34011992
PMC: 8134586.
DOI: 10.1038/s41598-021-90110-z.
Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy.
Morris E, Neelapu S, Giavridis T, Sadelain M
Nat Rev Immunol. 2021; 22(2):85-96.
PMID: 34002066
PMC: 8127450.
DOI: 10.1038/s41577-021-00547-6.
Development of LT-HSC-Reconstituted Non-Irradiated NBSGW Mice for the Study of Human Hematopoiesis .
Adigbli G, Hua P, Uchiyama M, Roberts I, Hester J, Watt S
Front Immunol. 2021; 12:642198.
PMID: 33868276
PMC: 8044770.
DOI: 10.3389/fimmu.2021.642198.
Genetic in vivo engineering of human T lymphocytes in mouse models.
Weidner T, Agarwal S, Perian S, Fusil F, Braun G, Hartmann J
Nat Protoc. 2021; 16(7):3210-3240.
PMID: 33846629
DOI: 10.1038/s41596-021-00510-8.
Development of an Inflammatory CD14 Dendritic Cell Subset in Humanized Mice.
Iwabuchi R, Ide K, Terahara K, Wagatsuma R, Iwaki R, Matsunaga H
Front Immunol. 2021; 12:643040.
PMID: 33790912
PMC: 8005643.
DOI: 10.3389/fimmu.2021.643040.
Building the Next Generation of Humanized Hemato-Lymphoid System Mice.
Martinov T, McKenna K, Hong Tan W, Collins E, Kehret A, Linton J
Front Immunol. 2021; 12:643852.
PMID: 33692812
PMC: 7938325.
DOI: 10.3389/fimmu.2021.643852.
Der p 2.1 Peptide Abrogates House Dust Mites-Induced Asthma Features in Mice and Humanized Mice by Inhibiting DC-Mediated T Cell Polarization.
Klein M, Colas L, Cheminant M, Brosseau C, Sauzeau V, Magnan A
Front Immunol. 2020; 11:565431.
PMID: 33312170
PMC: 7708318.
DOI: 10.3389/fimmu.2020.565431.
